A phase 3 study comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs. Lenalidomide and Dexamethasone (Rd) in subjects with previously untreated Multiple Myeloma who are Ineligible for High Dose Therapy

A randomized, double-blind, multicenter study of Denosumab compared with Zoledronic Acid (Zometa) in the treatment of Bone Disease in subjects with newly diagnosed Multiple Myeloma